No mention of UBS but McLean Capital Management upgraded INSMED INC (INSM from SELL to NEUTRAL.
Yes last opinion on insm at UBS was june 6th 2013. I should have looked be f ore my post but th e re is a run at $17.50. Its just less sure now. But we will get there.